Yuji Basaki

1.8k total citations
27 papers, 1.5k citations indexed

About

Yuji Basaki is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuji Basaki has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Yuji Basaki's work include Angiogenesis and VEGF in Cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yuji Basaki is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yuji Basaki collaborates with scholars based in Japan, United States and Australia. Yuji Basaki's co-authors include Michihiko Kuwano, Mayumi Ono, Yoshinao Oda, Masazumi Tsuneyoshi, Masayoshi Kage, Fumihito Hosoi, Akihiko Kawahara, Kazutaka Nakashima, Takashi Eguchi and Takashi Yao and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuji Basaki

27 papers receiving 1.5k citations

Peers

Yuji Basaki
Yuji Basaki
Citations per year, relative to Yuji Basaki Yuji Basaki (= 1×) peers Louis Hornez

Countries citing papers authored by Yuji Basaki

Since Specialization
Citations

This map shows the geographic impact of Yuji Basaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Basaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Basaki more than expected).

Fields of papers citing papers by Yuji Basaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Basaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Basaki. The network helps show where Yuji Basaki may publish in the future.

Co-authorship network of co-authors of Yuji Basaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Basaki. A scholar is included among the top collaborators of Yuji Basaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Basaki. Yuji Basaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Chizuko, Yuji Basaki, Akihiko Kawahara, et al.. (2010). Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations. Cancer Research. 70(21). 8715–8725. 141 indexed citations
2.
Kawahara, Akihiko, Koichi Azuma, Satoshi Hattori, et al.. (2010). The close correlation between 8-hydroxy-2′-deoxyguanosine and epidermal growth factor receptor activating mutation in non–small cell lung cancer. Human Pathology. 41(7). 951–959. 9 indexed citations
3.
Basaki, Yuji, Kenichi Taguchi, Hiroto Izumi, et al.. (2010). Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. European Journal of Cancer. 46(5). 954–965. 72 indexed citations
4.
Aoki, Daisuke, Yoshinao Oda, Satoshi Hattori, et al.. (2009). Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma. Clinical Cancer Research. 15(4). 1473–1480. 55 indexed citations
5.
Azuma, Koichi, Akihiko Kawahara, Yuji Basaki, et al.. (2009). Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(9). 1066–1074. 51 indexed citations
6.
Oda, Yoshinao, Kentaro Kuroiwa, Mayumi Ono, et al.. (2009). N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Human Pathology. 41(2). 214–222. 50 indexed citations
7.
Fujii, Teruhiko, Akihiko Kawahara, Yuji Basaki, et al.. (2008). Expression of HER2 and Estrogen Receptor α Depends upon Nuclear Localization of Y-Box Binding Protein-1 in Human Breast Cancers. Cancer Research. 68(5). 1504–1512. 69 indexed citations
8.
Watari, Kosuke, Shintaro Nakao, Abbas Fotovati, et al.. (2008). Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-κB activation. Biochemical and Biophysical Research Communications. 377(3). 826–831. 89 indexed citations
10.
Yano, Hirohisa, Yuji Basaki, Shinji Oie, et al.. (2007). Effects of IFN- α on α -Fetoprotein Expressions in Hepatocellular Carcinoma Cells. Journal of Interferon & Cytokine Research. 27(3). 231–238. 5 indexed citations
11.
Oda, Yoshinao, Takashi Eguchi, Shin-ichi Aishima, et al.. (2007). Expression profile of class I histone deacetylases in human cancer tissues. Oncology Reports. 18(4). 769–74. 281 indexed citations
12.
Ohishi, Yoshihiro, Yoshinao Oda, Yuji Basaki, et al.. (2007). Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecologic Oncology. 105(3). 586–592. 45 indexed citations
13.
Aishima, Shinichi, Yuji Basaki, Yoshinao Oda, et al.. (2006). High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma. Cancer Science. 97(11). 1182–1190. 47 indexed citations
14.
Yano, Hirohisa, Sachiko Ogasawara, Seiya Momosaki, et al.. (2006). Growth inhibitory effects of pegylated IFN α‐2b on human liver cancer cells in vitro and in vivo. Liver International. 26(8). 964–975. 34 indexed citations
15.
Maruyama, Yuichiro, Mayumi Ono, Akihiko Kawahara, et al.. (2006). Tumor Growth Suppression in Pancreatic Cancer by a Putative Metastasis Suppressor Gene Cap43/NDRG1/Drg-1 through Modulation of Angiogenesis. Cancer Research. 66(12). 6233–6242. 134 indexed citations
16.
Kobayashi, Hisayuki, et al.. (2005). Involvement of integrin-linked kinase in capillary/tube-like network formation of human vascular endothelial cells. Biological Procedures Online. 7(1). 41–47. 11 indexed citations
17.
Basaki, Yuji, Koichi Ikizawa, Keiichi Kajiwara, & Yukiyoshi Yanagihara. (2002). CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cε transcription in a human B cell line. Archives of Biochemistry and Biophysics. 405(2). 199–204. 14 indexed citations
18.
Yanagihara, Yukiyoshi, Yuji Basaki, Koichi Ikizawa, & Keiichi Kajiwara. (1997). Possible Role of Nuclear Factor-κB Activity in Germline Cϵ Transcription in a Human Burkitt Lymphoma B Cell Line. Cellular Immunology. 176(1). 66–74. 20 indexed citations
19.
Yanagihara, Yukiyoshi, Yuji Basaki, Keiichi Kajiwara, & Koichi Ikizawa. (1997). A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-κB. Journal of Allergy and Clinical Immunology. 100(6). S33–S38. 15 indexed citations
20.
Ikizawa, Koichi, et al.. (1996). Evidence for a Role of Phosphatidylinositol 3-Kinase in IL-4-Induced Germline Cϵ Transcription. Cellular Immunology. 170(1). 134–140. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026